A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies
HOTTE, Sébastien J, HIRTE, Hal W, OZA, Amit M, CHEN, Eric X, SIU, Lillian L, LE, Lyly H, COREY, Alfred, IACOBUCCI, Anne, MACLEAN, Martha, LO, Larry, FOX, Norma Lynn
Published in Clinical cancer research (01.06.2008)
Published in Clinical cancer research (01.06.2008)
Get full text
Journal Article
Targeted therapy for advanced renal cell carcinoma
Coppin, C, Le, L, Porzsolt, F, Wilt, T
Published in Cochrane database of systematic reviews (23.04.2008)
Published in Cochrane database of systematic reviews (23.04.2008)
Get more information
Journal Article
CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome
Cremin, Carol, Howard, Sarah, Le, Lyly, Karsan, Aly, Schaeffer, David F, Renouf, Daniel, Schrader, Kasmintan A
Published in Hereditary cancer in clinical practice (07.03.2018)
Published in Hereditary cancer in clinical practice (07.03.2018)
Get full text
Journal Article
Identification of Serum Amyloid A as a Biomarker to Distinguish Prostate Cancer Patients with Bone Lesions
Le, Lyly, Chi, Kim, Tyldesley, Scott, Flibotte, Stephane, Diamond, Deborah L, Kuzyk, Michael A, Sadar, Marianne D
Published in Clinical chemistry (Baltimore, Md.) (01.04.2005)
Published in Clinical chemistry (Baltimore, Md.) (01.04.2005)
Get full text
Journal Article
Phase I study of the multidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumours
LE, Lyly H, MOORE, Malcolm J, SIU, Lillian L, OZA, Amit M, MACLEAN, Martha, FISHER, Bryn, CHAUDHARY, Ajai, DE ALWIS, Dinesh P, SLAPAK, Christopher, SEYMOUR, Lesley
Published in Cancer chemotherapy and pharmacology (01.08.2005)
Published in Cancer chemotherapy and pharmacology (01.08.2005)
Get full text
Journal Article
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial
Khalaf, Daniel J, Annala, Matti, Taavitsainen, Sinja, Finch, Daygen L, Oja, Conrad, Vergidis, Joanna, Zulfiqar, Muhammad, Sunderland, Katherine, Azad, Arun A, Kollmannsberger, Christian K, Eigl, Bernhard J, Noonan, Krista, Wadhwa, Deepa, Attwell, Andrew, Keith, Bruce, Ellard, Susan L, Le, Lyly, Gleave, Martin E, Wyatt, Alexander W, Chi, Kim N
Published in The lancet oncology (01.12.2019)
Published in The lancet oncology (01.12.2019)
Get full text
Journal Article
Epidermal growth factor receptor expression in anal canal carcinoma
LE, Lyly H, CHETTY, Runjan, MOORE, Malcolm J
Published in American journal of clinical pathology (01.07.2005)
Published in American journal of clinical pathology (01.07.2005)
Get full text
Journal Article
A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209
Eigl, Bernhard Josef, Chi, Kim, Tu, Dongsheng, Hotte, Sebastien J, Winquist, Eric, Booth, Christopher M, Canil, Christina, Potvin, Kylea, Gregg, Richard, North, Scott, Zulfiqar, Muhammad, Ellard, Susan, Ruether, Joseph Dean, Le, Lyly, Kakumanu, A Saranya, Salim, Mohammad, Allan, Alison L, Feilotter, Harriet, Theis, Ashley, Seymour, Lesley
Published in Oncotarget (30.01.2018)
Published in Oncotarget (30.01.2018)
Get full text
Journal Article
CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma
Schaeffer, David F, Howard, Sarah, Renouf, Daniel, Karsan, Aly, Schrader, Kasmintan A, Cremin, Carol, Le, Lyly
Published in Hereditary cancer in clinical practice (07.03.2018)
Get full text
Published in Hereditary cancer in clinical practice (07.03.2018)
Journal Article
A randomized phase II study of pelareorep (REO) plus docetaxel vs. docetaxel alone in patients with metastatic castration resistant prostate cancer (mCRPC): Canadian Cancer Trials Group study IND 209
Eigl, Bernhard J., Winquist, Eric, Tu, Dongsheng, Hotte, Sebastien J., Canil, Christina M., Gregg, Richard William, Zulfiqar, Muhammad, North, Scott A., Ellard, Susan, Ruether, Joseph D., Le, Lyly H., Kakumanu, Ankineedu Saranya, Theis, Ashley, Booth, Christopher M., Potvin, Kylea R., Chi, Kim N., Seymour, Lesley
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Phase I and pharmacokinetic study of fostriecin given as an intravenous bolus daily for five consecutive days
Lê, Lyly H, Erlichman, Charles, Pillon, Linda, Thiessen, Jake J, Day, Andrew, Wainman, Nancy, Eisenhauer, Elizabeth A, Moore, Malcolm J
Published in Investigational new drugs (01.04.2004)
Published in Investigational new drugs (01.04.2004)
Get full text
Journal Article
A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate
Khalaf, Daniel Joseph, Avilés, Claudia M, Azad, Arun A, Sunderland, Katherine, Todenhöfer, Tilman, Eigl, Berhard J, Finch, Daygen, Le, Lyly, Atwell, Andrew, Keith, Bruce, Kollmannsberger, Christian, Chi, Kim N
Published in Canadian Urological Association journal (01.02.2018)
Published in Canadian Urological Association journal (01.02.2018)
Get full text
Journal Article
CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome
Cremin, Carol, Howard, Sarah, Le, Lyly, Karsan, Aly, Schaeffer, David F, Renouf, Daniel, Schrader, Kasmintan A
Published in Hereditary cancer in clinical practice (01.01.2018)
Published in Hereditary cancer in clinical practice (01.01.2018)
Get full text
Report